Feedback Share Chat (FDBK)

Imo

The use of AI is to replace the existing triage system that presently involves you discussing your symptoms with a nurse etc on telephone. It’s common now that many people look up their symptoms using AI at home. Before contacting there GP etc…so using /. Copying similar language.

Bleepa is a communication tool that is clinician / health processional facing….allows confidential communication and collaboration between medics of all kinds via the patients own records, removing unnecessary appts, providing clear simple patient pathways…( e.g straight to test so to remove initial outpatient appt) maybe open to other agencies in future social services, etc in neighbourhood health services.etc

However, now partnered with (PKB ). (PKB) is a secure online personal health record where you can see most of your hospital appointment letters, laboratory results and radiology reports…via the NHS app.

The nhs APP is more patient facing so patient can see there own records, add information , communicate with health professionals etc access live real time up to date data of their treatment history and results etc…

Imo

The use of AI is to replace the existing triage system that presently involves you discussing your symptoms with a nurse etc on telephone. It’s common now that many people look up their symptoms using AI at home. Before contacting there GP etc…so using /. Copying similar language.

Bleepa is a communication tool that is clinician / health processional facing….allows confidential communication and collaboration between medics of all kinds via the patients own records, removing unnecessary appts, providing clear simple patient pathways…( e.g straight to test so to remove initial outpatient appt) maybe open to other agencies in future social services, etc in neighbourhood health services.etc

However, now partnered with (PKB ). (PKB) is a secure online personal health record where you can see most of your hospital appointment letters, laboratory results and radiology reports…via the NHS app.

PKB) can be accessed securely online via the NHS app or the PKB website for patients in Sussex only at present…trialing.

The NHS app is an evolving thing….one day the aim is it will be the front door to the NHS ….a door into your own live health records, secure access to a doctor either locally face to face or more quickly by remote video…where you can add info and other medics in any geographical area …even abroad could access your medical notes and test results and record live events as they happen.

The nhs APP presently is more patient facing so patient can see there own records, add information , communicate with health professionals etc access live real time up to date data of their treatment history and results etc…

All in my opinion…GL vas

BBC article published today. The NHS App looks to have a central role to play for how the NHS develops & moves forward digitally. Unclear how FDBK could leverage their Bleepa offering to become a key part of this path forward……Thoughts?

NHS app to use AI to determine which service best for patients https://www.bbc.co.uk/news/articles/c0my2kjjnp2o

NHS Providers (now known as The NHS Alliance)

The NHS Alliance Insight Partners are organisations that work with and supply services to the NHS.

Reassuring to find Bleepa listed as partner.

https://thenhsalliance.org/partnerships/meet-our-insight-partners

Don’t forget mp12346.

Andy Burnham is well aware of Bleepa as he was actually present at the Neighbourhood Health Simulation in Manchester. He is mentioned as being present as a special guest by FDBK in their. iG post stating

“ As Andy said, today’s simulation has huge similarities with Manchester’s model - LiveWell. For me that’s one of the key take homes; a lot of the models already exist but need to be scaled, this is where digital approaches can help. Initiatives like LiveWell can be turbocharged with the right platforming, enabling them to reach more people and to scale their impact.

Don’t forget mp12346.

Andy Burnham is well aware of Bleepa as he was actually present at the Neighbourhood Health Simulation in Manchester. He is mentioned as being present as a special guest by FDBK in their. iG post stating

“ As Andy said, today’s simulation has huge similarities with Manchester’s ( neighbourhood) model - LiveWell. For me that’s one of the key take homes; a lot of the models already exist but need to be scaled, this is where digital approaches can help. Initiatives like LiveWell can be turbocharged with the right platforming, enabling them to reach more people and to scale their impact.”

https://www.linkedin.com/posts/drthomasoakley_bleepa-activity-7394075168954015745-MWzw

Sounds like Burnham has it in for them, hopefully leaves space for us somewhere along the line.

17th June 2026

"Knows Best record system, which will allow acute services’ patients to view and manage hospital information online, including the ability to request appointment changes.

The department’s director of digital health, Martin Carpenter, told a recent meeting of the Health and Care Jersey Advisory Board that the current plan is to introduce this in stages, beginning with appointments and selected correspondence, followed by test results.

He added that the programme will begin with an initial trial with a small group of patients and, subject to the outcome, may then be rolled out more widely on a department‑by‑department basis, with additional functionality introduced over time.

The ‘PKB’ system is already widely used within the NHS.

The government’s budget this year included an extra £8m for digital health services. A key part of this is creating a single electronic patient record, as part of a £32m ‘digital transformation’ programme."

https://jerseyeveningpost.com/news/2026/06/17/hospital-to-trial-system-allowing-patients-to-request-appointment-changes-online/

Is a Venture Capital Trust (VCT) and published there Final Results on 17 June 2026.

They write about a number of company's including FDBK performance where they stated

"Feedback’s shares came under pressure despite continued progress in expanding its commercial opportunity. The business has experienced disruption linked to changes in NHS funding amid broader healthcare reforms, although conditions now appear to be stabilising. Bleepa, the company’s main technology, a clinical communication platform enabling the secure sharing of patient data and medical images, remains well aligned with NHS priorities around improving efficiency and increasing investment in digital infrastructure, with a growing number of trials underway across the country."

I imagine that Octopus VCT talk to the company so the fact that they were and remain positive ten days ago may count for something, maybe!

.https://www.londonstockexchange.com/news-article/OOA/final-results/17643097

You said the same thing when Wes Streeting resigned.

I haven’t heard that Tom has been side-hustling as Starmer’s or the Labour Party’s spokesperson, so I honestly don’t see why Oakley needs to address shareholders every time there’s political movement in government 😄

Sure, changes could create delays and potentially increase the chance of an additional equity raise -that’s a fair discussion. But the UK will likely be on its 8th Prime Minister in around 10 years. So I guess, non elected government officials and NHS leadership have plenty of experience dealing with constant political change.

Also, NHS reform is one of Labour’s flagship policies — something they repeatedly point to as evidence of delivery. Whoever comes next is more likely to continue the reform agenda, or even accelerate it, rather than reverse it.

The bigger question isn’t whether government changes. It’s whether Feedback was ever actually included in the NHS 10-Year Plan. If it wasn’t, then neither a stable government nor a changing one will make much difference. If it is, however, then the opportunity could be enormous.

Looks like more revolving doors with Starmer likely to go I can't think this helps the timetable I think an equity raise is now very much likelier. I wonder if Tom will give the faithful an update. ?

I'm looking at what's around regarding " Straight To Test", and what if any funding is behind it, as we know Straight to Test is a main pillar of FDBKs new pathway...where GP can refer straight to tests, before patient sees the consultant or whatever health professional , if any the tests dictate they see., saving potentially hundreds of thousands of unnecessary initial hospital appointments.

I found this "Inside the NHS’s National Cancer Plan for England 2026-2035"

https://www.carnallfarrar.com/inside-the-nhss-national-cancer-plan-for-england-2026-2035/

The plan centres on “patient-first care” with four core pillars:

Community-first care: Most cancer care will move outside hospitals by 2035, with straight-to-test pathways for top 10 specialities, a £2.3bn Community Diagnostic Centre investment, and named lead for every patient from 2028.

"Data, digital and AI: New technologies will transform cancer care delivery and access. The Federated Data Platform tool Cancer 360 will centralise patient data by 2026/27, enabling clinicians to prioritise those most in need and see patients quicker. From 2028, the NHS App will become the primary cancer access point, with a Single Patient Record providing seamless data sharing across the system. Chest X-ray AI will be deployed across all trusts to enhance diagnostic accuracy and speed."

In

The NHS is preparing to reopen its £1 billion Workforce Systems 2 Open Framework, creating a massive entry point for suppliers of HR, rostering, recruitment, and learning technologies.

As workforce management remains one of the NHS’s biggest operational hurdles, this framework serves as the national, compliant route for healthcare buyers to procure software and digital solutions that support staff deployment and wellbeing.

If your organisation provides workforce software, integration services, or digital transformation consultancy, missing this reopening means being locked out of major UK healthcare spend.

See full information

Neuven Consult has a 98% success rate getting businesses onto public sector frameworks. If you want to be one of the selection, email back to arrange a call. We'll review where you stand and what needs to be in place before submission windows close.

Best regards,

Neuven Consult

Just thought i would have a quick look at Optum and PPL to see there relationship with Microsoft and Copilot.

https://www.healthcarefinancenews.com/news/optum-real-microsoft-partner-ai-claims-and-reimbursement

PPL rolls out Microsoft 365 Copilot Chat company-wide, becoming one of the first in the industry to scale up Enterprise AI enablement

https://www.ppl.com.pk/content/ppl-rolls-out-microsoft-365-copilot-chat-company-wide-becoming-one-first-industry-scale

Hello Bill, Good to see your still hanging in here.

If we allow ourselves to be positive for a moment and imagine a possible national rollout , or part of a rollout for Bleepa sometime later this year then the article below looks much more Interesting"

maybe, just maybe Bleepa could get a similar award ! Its what we have been told to expect , just need the confirmation.

This award ( to Copilot Microsoft 365) was made recently, following a pilot / trial. Bleepa is still on trial at QVH and pathways expanding , and also hits the same general targets as identified for reason of purchase this Microsoft software in the case below, so is still relevant. The rollout below is for employing an AI tool across the entire nhs ...to save staff time, save money, efficiency, easier pathways, accelerating digitalization, access to data etc etc plus Bleepa also adds further value to the patients.

"Each NHS trust will receive a central allocation of licences based on organisational headcount, typically starting at around 2,000 Copilot Microsoft 365 licences. Rollout to more than 500,000 staff across the NHS is expected by October 2026.

The NHS wants to embrace cutting-edge technology and this Microsoft partnership will mean staff can be freed from admin so they can focus more of their time on what matters most – improving care for patients."

GL Vas

https://www.wired-gov.net/wg/news.nsf/articles/500000+NHS+staff+to+get+new+artificial+intelligence+tools+to+help+free+up+more+time+for+patients+09062026091500

Published 12th June. Mostly reiterating what's been said before.

https://www.emishealth.com/news-insights/data_and_insight_to_transform_neighbourhood_care

Still in with a chance but the SP is depressing hence my silence of late

I’m hoping that they now expect to have a new customer! Or two…

Otherwise it’s just a replacement for the last Success Executive who probably left due to boredom or loneliness!

What is a Customer Success Executive?

Customer Success Executive manages post-sales client relationships, focusing on onboarding, user adoption, retention, and account growth.

They collaborate with internal teams to drive product value and ensure clients achieve their business goals while identifying upsell and cross-sell opportunities.

The role blends relationship management and commercial strategy. Key responsibilities for the position include:Onboarding & Adoption: Guiding new customers through setup and ensuring they are actively utilizing your product or service.Relationship Building: Acting as the main point of contact, conducting business reviews, and addressing client concerns proactively.Commercial Growth: Spotting opportunities to upgrade or expand the client's current package (cross-selling and upselling).

Analytics: Monitoring key metrics like client satisfaction and churn, and reporting this data to internal stakeholders.

Can’t knock their optimism 😀

Customer Success Executive

Closing date 12th June 26

https://feedbackmedical.com/vacancy/customer-success-executive/

Yes, it does seem like that!

tom was awarded a Fellow at the NHS Innovation Accelerator (NIA): An NHS England initiative delivered in partnership with the 15 Health Innovation Networks (formerly known as AHSNs) and backed by the UK government .

The NIA

“ The NIA is an award-winning initiative, working to support NHS Long Term Plan priorities by accelerating uptake of promising innovations for patient, population and NHS staff benefit. Delivered by the Health Innovation Network, the NIA is commissioned by the NHS Accelerated Access Collaborative. Selected following a rigorous application process, NIA Fellows are chosen because they offer a unique solution designed to address some of the most pressing challenges facing healthcare today.”

Let’s hope Bleepa remains aUnique Solution😊

All the previous information you’ve posted points to exactly what Bleepa is doing. It almost sounds like Oakley wrote those articles himself 😄

At this point, I think it’s evident that there won’t be any middle ground for Feedback. Either the product is selected for a regional or national rollout, or it becomes largely irrelevant.

If the NHS manages to deliver on the ambitions described in those articles without using Bleepa, it would mean they have either built a comparable solution themselves or found some previously unknown provider capable of delivering the same functionality. That would be quite surprising, considering Bleepa is already a tested and deployed solution within the NHS rather than a theoretical concept still waiting to be proven.

Established only a few days ago on 1 st June 2026. It aims to

Provide online consultations across the nation , live in early 2027 ,currently approx six months time !

This service yet again screams out for a Bleepa type solution .

I now wondering if this is what the company are waiting on as far as one sauce of funding delayed to end of year.

https://www.england.nhs.uk/digitaltechnology/nhs-online/

The business secretary says government will ‘take more risks’ by using taxpayer money to back British firms and innovation and jump-start economic growth

exclusive

Peter Kyle, Secretary of State for Business and Trade, at the Emma Bridgewater pottery factory.

Peter Kyle: “I want us to be aggressively ambitious”

PAUL TONGE FOR THE SUNDAY TIMES

Oliver Gill

Oliver Gill, Deputy Business Editor

Saturday June 06 2026, 2.01pm, The Sunday Times

Listen

• 6:20 min

Share

Prefer us on Google

Britain is to unleash a major new wave of corporatism, in which the state will “aggressively” take larger stakes in fast-growing private sector firms to jump-start economic growth.

Business secretary Peter Kyle will use London Tech Week, starting on Monday, to set out his vision for rebooting the economy. Billions of pounds of previously announced taxpayer aid will be used to take bigger stakes in the country’s next winners. This will result in UK taxpayers owning far more of privately owned businesses than has previously been the case.

https://www.thetimes.com/article/5b7a8eb4-3f3e-4051-a2e2-21ecf7416028?shareToken=2ee7220ee634660589205f95fa01c7b5

By coincidence It seems FDBK have posted an article regarding Frontline Productivity entitled

"Optimising digital pathways: Unlocking frontline productivity in the NHS"

https://feedbackmedical.com/insights/frontline-productivity-in-the-nhs/

The nhs / Government change from the Frontline Digitalzation programme to the newly named Frontline Productivity Programme . Launched following the milestone of near-universal Electronic Patient Record (EPR) coverage along with all funding . It is this change that has caused the funding for Bleepa and others to be delayed by 6- 9 months from last April 26.

In the RNS update in April 26 Tom stated

“ Previous indications were that a central NHS decision would be made in relation to a potential contract for adoption of a widescale programme for Bleepa around the end of the 2025/26 NHS financial year (31 March 2026). The Company now understands that decisions will be delayed by at least 6-9 months due to NHS internal factors.”

So now it seems the NHSis full of technology ,nearly 200% EPA’s (electronic patient records) etc ….it now needs the tools to get the maximum benefit from them…..Bleepa software is one way.

So below is more info about The Productivity Programme.

“ While Frontline Digitisation focused on deploying EPRs in secondary care, its successor tackles a harder challenge: maximising productivity gains from effective, consistent use of existing digital systems across all care settings.

This shift is urgent. The NHS must deliver sustained 2% year-on-year productivity improvements, reduce workforce administrative burden, and accelerate care delivery while managing unprecedented demand. Yet many organisations are confronting a difficult truth: having digital systems and using them effectively are very different challenges. ”

“ As Frontline Productivity launches in April 2026, organisations must demonstrate how investments deliver against the four spending objectives while contributing to 2% year-on-year productivity gains. Infrastructure choice matters: generic tools lack NHS validation, while bespoke development diverts scarce resources. ”

https://futurescot.com/from-digital-acquisition-to-digital-exploitation-why-nhs-frontline-productivity-depends-on-adoption/

Appears that the problem and the solution are both covered in these last couple of posts. The two must surely be aware of each other!

Thanks JJ,

I have the same feeling as you and can see how this investment can suddenly turn good, very good once the funding flows.

I honestly think that on at least one occasion FDBK had cracked it, only to be thwarted by the elections.

I sold over half on the last RNS and will be buying again over the next few weeks …..I’m very confident there is a place for Bleepa in the new NHS , and I’m sure the company know this also, but can’t comment until first funding is received. Gl vas

Found this from April , which is new to me.

https://nhsaccelerator.com/insights/two-nhs-innovation-accelerator-innovations-join-forces-to-deliver-connected-patient-centred-pathways/

Great find, Vas, as always.

It’s been an extremely frustrating couple of years for shareholders. The last RNS certainly didn’t help, so the slow bleed in the share price since then is completely understandable.

What’s almost unbelievable, though, is how many dots have been connected for this company over the years, yet there always seems to be one missing piece usually due to external factors that prevents the magic from happening.

I’ve been a fairly successful investor for quite some time, and I’ve never had a problem cutting a losing position and moving on when the investment case changes.

However, this stock is by far my longest-held position, and despite all the frustration, I’ve continued averaging down. Whether it’s Warren Buffett-level analysis 😄, gut feeling, wishful thinking, or pure blindness, I honestly don’t know.

But I still believe that one day this company could become something big.

MPs to debate NHS single patient record after data concerns

https://www.bbc.co.uk/news/articles/cp3pgd9gzy3o

Bleepa is Registered as a Class A medical device , is has a Certification against the UK government Cyber Essentials and Cyber Essentials Plus standards. and aligned with the NHS Digital Technology Assessment Criteria (DTAC).

and complies with the DCB0129 Clinical Safety Standard.

Big gamble here. Company today worth just £3.4 m, less than 25% of shares held privately, presently on year and All time low….. FDBK have no had new contracts awarded for ages , not because their solutions are poor but awaiting the funding from NHS to be awarded. Could be another six months before funding announced but we only need an unexpected contract to be awarded sooner, and the sp should rocket.

A fan of buy british

Excellent find Vascular, I noticed this too in one of the recent resignation letters from Zubir Ahmed who is minister for NHS tech, now out of a job but surely the work they were doing wil be delayed rather than cancelled.

“I have also been proud to use my clinical experience to accelerate the digital transformation of our NHS and had been planning the rollout of the NHS online hospital later this year”

More details here about buying British technology

"Chancellor Rachel Reeves is set to announce a landmark shift in public procurement......The NHS tech investment strategy will now mandate that the National Health Service and the Ministry of Defence (MoD) prioritise homegrown British technology and artificial intelligence (AI) over foreign competitors.......Minister Spencer Livermore has admitted that the UK government is often “too slow” to adopt new technologies, frequently leaving British innovators without a “first customer” in their home market.

Where Will These Tech Investments Be Deployed?

NHS Trusts Nationwide: From London to Newcastle, hospitals will see a transition toward British-made AI diagnostic tools and data management systems."

https://www.uknewsblog.co.uk/uk-buy-british-tech-policy-nhs-and-defence-to-prioritise-domestic-ai/

High mp12345,

I cant find anything exclusively mentioning NHS either but i do recall this from the withdraw from Plantir supplying technology to NHS a month or so ago

"The UK government has promised a different approach to tech procurement following the award of controversial contracts to Palantir. Speaking to MPs, science minister Patrick Vallance said that the government's deals with Palantir – which has large contracts with the NHS and the Ministry of Defence – would be done differently in the future, instead emphasizing investment in UK technology and companies."

GL Vas

Out today. An explanation form FDBk's sale manager one of one of the Health Departments key targets and how FDBK can help them achieve this.

Just need the actual sales now...and we will be smiling.

Any sign of the slightest news here and i expect some kind of fireworks, followed by a celebratory Bank Holiday and a fly over from the Blue Arrows plus a quick 60% instant surge in the sp, just to start with.

https://www.linkedin.com/posts/feedback-medical-ltd_whilst-leftward-shift-and-moving-care-into-activity-7465031514255450113-dDJP

Optum uk bought

https://www.digitalhealth.net/2026/05/gp-it-supplier-optum-acquired-by-us-equity-firm-tpg/

How much bad luck can one company have? I'm not sure what effect , if any the Heath Minister stepping down could cause, but its not the good news i was hoping for. There is no way Tom et al could have foreseen this move, along with the delay in procurement to end of year news announced a while ago.

Hope something comes up for them as they ( and we) deserve a break imo

Yet more delay Tom ? Care to update your investors on the impact given your previous comment about the adverse effect of the revolving door for heath minister ?

Actually this Wednesday looks like a huge policy milestone IF (and I emphasise IF) the feedback is somewhere near with SPR. Let’s wait and see — would be nice to hear some positive movement even before that sad 6–9 month period mentioned in the last RNS.

https://www.theguardian.com/society/2026/may/10/gps-and-hospitals-in-england-to-be-required-to-share-data-to-create-single-patient-records

I hope they drop some positive news soon …., just a taster! If only to get us through the summer.

Newsflow about NHS data under one roof hitting mainstream.

Unsure if this is positive in anyway for f#ckback?

Would hope that Labour would pick low hanging fruit?

Jx5,

Your guess is as good as Keir Starmer's!!

No direction, plan or strategy about anything pre- elections. Unlikely we'll see anything better going forward from the current occupant of No10 and given the quality of potential replacements, I can't see any change. And I include the current Health Secretary, Wes Streetling

Only two options for PIs. Sell and take the hit or hold and hope for some decision making favourable to FDBK.

ing

Would be great to hear some thoughts from UK-based investors regarding the possible direction of the government and its reforms.

After these local elections, what do you think the government’s direction will be? Do you expect Labour to continue pushing its NHS reforms more aggressively in order to demonstrate before the next general election that the reforms are actually delivering results? Or could there be some reversal or slowdown given the political pressure after the election losses?

And frankly what a time to reward a new incumbent when shareholders are hugely underwater and recently further disappointed. Poor judgement

Yes and no. One big contract and 20 p should be blown away. As Tom said at 20 p there's never been a better time to invest in Fdbk ! It's a shot to nothing Sorry maybe I am a bit tetchy but we have had three years of hype with no reward and someone walks in and hasn't done much except blur the facts. It's too early

PR,

That may well be the case but you surely agree that the vesting hurdles are extremely aggressive?

As for being a big hitter, I would suggest that applies to all on the BoD!!

A reward for obfuscation on the cash position which continues Ridiculous. She is not a big hitter.

Well, the BoD certainly has some optimism for the future!

Someone dump 68K pounds worth on the 20th obviously not prepared to wait anymore!!

Cough ... Dibs61 - whereve you gone??

Maybe someone really did mortgage their house betting Feedback would finally deliver 😄

At this point though, the ones still here probably aren’t betting the house anymore.

A ~30% drop on what looks like only ~5% of equity changing hands says more about sentiment than fundamentals. Structurally, not much has actually changed.

That said, it does feel like déjà vu from last April with once again, “non-Feedback-related circumstances” pushing timelines out (at some some point, Okley needs to take a hard look at how expectations are set and communicated🫣).

The next 6–9 months look like a low-expectations zone and that’s not necessarily a bad thing. When expectations are on the floor, it doesn’t take much to shift sentiment. The financial runway appears covered into mid-next year. The latest RNS also hints at possible additional funding from QVH this year, even a short extension of liquidity runway could help steady investor nerves.

Yes, cash is tight. But on the product side, things are clearly stronger: the product is there, pathways are expanding, integrations with other systems is progressing and awareness at policymaker level is improving.

So fundamentally, the setup looks better, even if liquidity remains the constraint.

Plenty of great companies have come close to running out of cash just before a turning point. Maybe it’s a bit of wishful thinking, but it still feels like we’re not far from one. And those moments of fear are often when wealth is created.

Someone dump 68K pounds worth on the 20th obviously not prepared to wait anymore!!

What’s the commercial value of all these partnerships? appears to be a way in via the back door to the nhs, but then how do we differentiate ourselves from the overall product being provided, from memory, there is never any monetary value attached to them? it feels like lots of people are using bleepa but no one apart from qvh seems to be paying for it.

I agree that there’s always another stock out there.

Personally, I’d rather stick with something I’ve followed closely for some time. The alternative is jumping into another penny stock making similar promises to Feedback, or trying to move money into large caps that already seem priced to perfection in a market that feels quite fragile.

For now, I think I’ll give Feedback and its so far poorly performing management team a bit more time. At least it’s valued far from perfection, and as I mentioned before, the product and its underlying need haven’t changed.

Ultimately, only time will tell.

I agree with you but if you can see another share you like in the meantime it may pay to switch. Apart from anything else the market doesn't like a share where you have to wait a long time for news. On top of that there will be a discount on an equity raise and I think that is likely. The share price today tells the story.

I hope it all works out but I am out for a while exploring other shares. Good luck.

JJJJJ, good post

For those of a nervous disposition, I suggest you check the link I posted at 08:15. Demonstrates very clearly the benefits of Bleepa integrated into PKB for pathway management. Also check how PKB is becoming embedded in the NHS

As painful as it is to once again see frustrating news about delays, timelines being pushed further down the road, and the share price losing a quarter of its value in the blink of an eye, moments like this make it incredibly difficult and absolutely crucial for me to remind myself why I still hold the stock.

As a healthcare professional with more than a decade of experience, not in the UK, but across several European countries, I genuinely believe that Bleepa would be a game changer in any modern healthcare system.

For those outside healthcare, terms used by Oakley such as “digital glue,” “cost-efficiency,” or “asynchronous healthcare” may sound like buzzwords. But in reality, these are exactly the elements that dysfunctional, outdated healthcare systems around the world desperately need.

So for me, the core investment case hasn’t changed. This is still a unique product that any healthcare system would benefit from immensely. Even if, at some point in the medium term, the company needs to raise additional capital, I don’t see that as catastrophic. It could still turn into an impressive multi-bagger.

I’ve already waited a long time for this to play out - I have no problem waiting a bit longer.

Dibs - was that your 200k shares running for the door earlier?

Was talking to someone over the weekend and they said about a group of NHS managers running something ... he asked them what will happen once they achieve this project roll out - ohh we'll rebadge and go do something else, it's how the system works ...

9 Months until decision time - no extra cash flow received from QVH and no trimming of the salary and overheads budget.

Next placing amount and price ???

I’m sure his massive salary takes the edge of that frustration.

Disappointed that the decision regarding the National funding is now expected over next nine months . The good news imo is this opportunity is still alive and kicking, and the longer FDBK continue in discussions the more promising the outlook imo.

There is no evidence these delays are related to FDBK ,and were partly expected dealing with the NHS ,going through a once in a generation transformation.

qVH imo will become part of the nhs blueprint along with other successful , continuing projects paid for by the centre.

Workflow for the insomnia pathway at QVH demonstrating PKB/Bleepa integration

https://wiki.patientsknowbest.com/space/MAN/5161648135/Bleepa

Not sure if this has been posted here before , even though dated , is a good read for anyone new to, or thinking of investing in FDBK as it covers all the main points imo. Plus emphasises the potential opportunity's here in the next few weeks and months , H1 26.

https://joshthompson.co.uk/investing/feedback-plc-h1-2025-results-bleepa-nhs-national-scale/#:~:text=Interpretation:%20Laying%20Track%20Before%20the,to%20flow%20from%202026/27.

Https://www.linkedin.com/posts/patients-know-best_university-hospitals-sussex-nhs-foundation-activity-7450522016324964352-wkrF?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAIMELYB3jCMTAJfoWG0WbiPY6veZrdjeEU

University Hospitals Sussex NHS Foundation Trust has switched off paper appointment letters for patients who use PKB. It is a decision that is on course to save the trust £1.2 million every year.

Before this, many people were getting the same information four different ways. It was a waste of money and also time. Clinical teams sometimes had to help fold paper letters just to get them out. Going digital-first is expected to give staff 25,000 hours back to spend with patients.

Despite fears to the contrary, DNAs (Did Not Attends) didn't go up. Because the team planned this so well, attendance actually improved.

Importantly, this was done closely with patients, and anyone who still needs paper can have it.

We know these changes take a lot of preparation. Congratulations to Adam Pearson and the team at UHS for seeing it through - and thank you for sharing your experience for others to learn from ⬇️

Vas - many thanks. I also sincerely hope the patience and resolve of LTH’s here is rewarded. It would be richly deserved.

In terms of the purchases today, who knows, though one thing is certain. Someone ALWAYS knows something.

National NHS business case submitted → decision pending (H1 2026)

Fingers crossed

Life in the old dog!!

I feel the same as you. Good luck with your most recent purchases. Hopefully your timing will be spot on.

Wonder what made someone suddenly go on a 30k buying spree?

Vas only one of the trades printed today is mine:

17-Apr-26 13:50:43 12.95 10,000 1,295 O

The rest…. I have no idea? However I did purchase 50k a few sessions ago @ 12.3 and 12.45

I think positive news is coming v soon. Very positive developments taking place with PKB which are going to lead to fruitful results.

Vascular - I want to see National to give them the contract size to cover the last and the next placing shares in issue.

Local, one hospital contracts shared with partners won't be able to cover their cost base imo.

Spent some time recently going through Bleepas blog posts - theyve got some staff that is for sure and some issues that need constantly solving and adapting into.

Hi Llama,

Optum / EMIS have approx 84 trusted partners who’s technology solutions are presently working with primary and secondary care in the UK NHS.

Feedback as a solutions partner to Optum can now, and in future, work alongside and integrated with any or all of these 84 solutions if required across the entire nhs.

Only a few of the 84 may go national , but via Optum FDBK have access for further partnerships, in theory.

The rewards from working in partnerships such as these offers some insurance if Bleepa is not selected for a National rollout.

Just my view and I know only what you know, so just an opinion .

https://www.emishealth.com/partners

Patients Know Best.

Balance sheet as at 31/12/24 Negative (£3.8m)

Cash at Bank £2.19m

Look into how the deal will be structured... seed shares over Ordinary shares, the early doors seed investors may be waiting for you :)

THE ORDINARY SHARES CARRY ONE VOTE PER SHARE AND RANK PARI PASSU WITH THE

SERIES SEED SHARES, SERIES A1 SHARES, SERIES A2 SHARES AND SERIES A3 SHARES

AS RESPECTS DIVIDENDS BUT BEHIND THE SERIES SEED SHARES, SERIES A1 SHARES,

SERIES A2 SHARES AND SERIES A3 SHARES AS RESPECTS DISTRIBUTIONS OF CAPITAL

ON A SALE. THE ORDINARY SHARES ARE NOT REDEEMABLE.

Is this a marriage of convenience born from necessity?

First sign they are getting somewhere I'll buy in for the NHS contracts and the Indian business that may well follow, but i'd want to see clarity, the business model doesn't look settled to me?

Thanks for sharing IBill,

As we know Emis , changed its name to Optum a while ago, who are now a partner with FDBK in the simulations etc

I can’t remember if I knew this and forgot , but Optum are partnered with Patients Know Best also

Looking like the makings of some kind of health consortium.

https://deploy.patientsknowbest.com/deploy/integrations/native-integrations/emis/es

IB,

Brilliant!!

Many thanks for posting